[1] |
Zhu RX, Seto WK, Lai CL, et al. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region[J]. Gut Liver, 2016, 10(3): 332-339.
|
[2] |
Dimitroulis D, Tsaparas P, Valsami S, et al. Indications, limitations and maneuvers to enable extended hepatectomy: current trends[J]. World J Gastroenterol, 2014, 20(24): 7887-7893.
|
[3] |
李科,林国桢,李燕,等.广州市2004-2013年原发性肝癌流行现况和趋势分析[J].中华肿瘤防治杂志,2016, 23(23): 1527-1530.
|
[4] |
Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of hepatocellular carcinoma[J]. Surg Oncol Clin N Am, 2015, 24(1): 1-17.
|
[5] |
Liu CY, Chen KF, Chen PJ. Treatment of liver cancer[J]. Cold Spring Harb Perspect Med, 2015, 5(9): a021535.
|
[6] |
Trevisani F, Garuti F, Neri A. Alpha-fetoprotein for diagnosis, prognosis, and transplant selection[J]. Semin Liver Dis, 2019, 39(2): 163-177.
|
[7] |
Wang X, Mao M, He Z, et al. Development and validation of a prognostic nomogram in AFP-negative hepatocellular carcinoma[J]. Int J Biol Sci, 2019, 15(1): 221-228.
|
[8] |
中国抗癌协会肝癌专业委员会,中华医学会肝病学分会肝癌学组,中国抗癌协会病理专业委员会,等.原发性肝癌规范化病理诊断指南(2015版)[J].中华肝胆外科杂志,2015, 21(3): 145-151.
|
[9] |
陆录,钦伦秀.美国癌症联合委员会肝癌分期系统(第8版)更新解读[J].中国实用外科杂志,2017(2): 141-145.
|
[10] |
Kudo M, Kitano M, Sakurai T, et al. General rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the Liver Cancer Study Group of Japan[J]. Dig Dis, 2015, 33(6): 765-770.
|
[11] |
Keane MG, Pereira SP. Improving detection and treatment of liver cancer[J]. Practitioner, 2013, 257(1763): 21-26, 2-3.
|
[12] |
Zhang Y, Ren JS, Shi JF, et al. International trends in primary liver cancer incidence from 1973 to 2007[J]. BMC Cancer, 2015, 15: 94.
|
[13] |
Petrick JL, Braunlin M, Laversanne M, et al. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007[J]. Int J Cancer, 2016, 139(7): 1534-1545.
|
[14] |
沈智勇,吴名凤,张亚力,等.超声测量肝癌大小与术后多预后因素相关分析[J].医学影像学杂志,2011, 21(12): 1842-1845.
|
[15] |
Meoni G, Lorini S, Monti M, et al. The metabolic fingerprints of HCV and HBV infections studied by nuclear magnetic resonance spectroscopy[J]. Sci Rep, 2019, 9(1):4128.
|
[16] |
Wang Q, Blank S, Fiel MI, et al. The Severity of liver fibrosis influences the prognostic value of inflammation-based scores in hepatitis B-associated hepatocellular carcinoma[J]. Ann Surg Oncol, 2015, 22 Suppl 3: S1125-1132.
|
[17] |
Carr BI, Guerra V, Giannini EG, et al. Significance of platelet and AFP levels and liver function parameters for HCC size and survival[J]. Int J Biol Markers, 2014, 29(3): e215-223.
|
[18] |
金晶兰,温晓玉.AFP分层有利于预测乙型肝炎相关肝癌预后[J]. 临床肝胆病杂志,2014, 30(4): 385.
|
[19] |
Chen Y, Qu H, Jian M, et al. High level of serum AFP is an independent negative prognostic factor in gastric cancer[J]. Int J Biol Markers, 2015, 30(4): e387-393.
|
[20] |
杨盛力.肝癌患者术前血清AFP水平对手术预后的影响[J].临床肝胆病杂志,2016, 32(12): 2257.
|